Health Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next Year
Healthcare software provider Health Catalyst (NASDAQ:HCAT) in Q4 CY2024, with sales up 6% year on year to $79.61 million. On the other hand, next quarter’s revenue guidance of $79 million was less impressive,
Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of -63.64% and 0.28%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 26, 2025 5:00 PM ETCompany ParticipantsJack Knight - Vice President,
Health Catalyst: Q4 Earnings Snapshot
SOUTH JORDAN, Utah (AP) — SOUTH JORDAN, Utah (AP) — Health Catalyst Inc. (HCAT) on Wednesday reported a loss of $20.7 million in its fourth quarter. The South Jordan, Utah-based company said it had a loss of 33 cents per share. Earnings, adjusted for stock option expense and amortization costs, came to 4 cents per share.
Earnings To Watch: Health Catalyst Inc (HCAT) Reports Q4 2024 Result
Health Catalyst Inc (NASDAQ:HCAT) is set to release its Q4 2024 earnings on Feb 26, 2025. The consensus estimate for Q4 2024 revenue is $79.67 million, and the earnings are expected to come in at -$0.
Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics
For the quarter ended December 2024, Health Catalyst (HCAT) reported revenue of $79.61 million, up 6% over the same period last year. EPS came in at $0.04, compared to $0.02 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $79.
Hosted on MSN5h
Signature Healthcare selects Ignite ecosystem to improve analytic capabilities
The healthcare delivery system will use Ignite to achieve its goals, including the integration of clinical and claims data.
Health Catalyst Reports Fourth Quarter and Year End 2024 Results
SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider ...
The Herald Journal1d
Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™
Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare ...
Teladoc Health: Needs A Growth Catalyst
Teladoc Health is a beaten-down stock with stagnant revenue, priced attractively relative to its sector. Read why I rate TDOC ...
Health Catalyst price target lowered to $10 from $13 at BTIG
BTIG analyst David Larsen lowered the firm’s price target on Health Catalyst (HCAT) to $10 from $13 and keeps a Buy rating on the shares after ...
Health Catalyst, Inc.: Health Catalyst Reports Fourth Quarter and Year End 2024 Results
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations ...